| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.02 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |